QUAL iShares MSCI USA Quality Factor ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| AAPL | 6.49% |
| NVDA | 6.28% |
| MSFT | 5.06% |
| META | 3.62% |
| TJX | 3.60% |
| LLY | 3.18% |
| V | 3.13% |
| LRCX | 2.95% |
| KLAC | 2.59% |
| MA | 2.52% |
ETF Analysis
Fund Overview
iShares MSCI USA Quality Factor ETF (QUAL) currently reports 121 stock positions (subject to change), placing it in the broadly constructed range by holdings breadth. The top line-up is AAPL (6.49%), NVDA (6.28%), MSFT (5.06%), with AAPL as the largest single weight at 6.49%. Together, the top three holdings account for 17.83%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.
Profitability & Capital Efficiency
Looking at how effectively the underlying holdings deploy capital, ROIC is 44.84%, WACC is 9.96%, and the economic spread is 34.88%. On balance, holdings are earning returns on capital well in excess of what investors and creditors require — the defining characteristic of a high-quality compounding portfolio. Supporting metrics show ROE at 58.55% and ROA at 16.25%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
On valuation, the portfolio registers trailing P/E of 26.71, forward P/E of 22.56, PEG of 2.35. The minimal trailing-to-forward compression implies limited earnings growth expectations are embedded in current prices. The PEG reading here implies the market is pricing growth at roughly fair value — a setup where the investment case depends more on execution than on multiple expansion. A current ratio reading of 2.15 points to holdings that are managing short-term obligations without apparent stress. Taken together, the multiple and liquidity picture suggests a portfolio that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.
Margins & Cash Generation
Across the three margin layers, gross margin sits at 56.96%, operating margin at 32.70%, and free cash flow margin at 24.36%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins this strong typically indicate a combination of pricing power, cost discipline, and operating leverage. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margins describe businesses that have earned their profitability rather than manufactured it through accounting — a meaningful quality signal.
Growth & Forward Outlook
On a forward-looking basis, TTM revenue growth of 16.77% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 19.02%, where the target distribution indicates incremental upside rather than outsized repricing. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.